Aakaar Medical Technologies (NSE:AAKAAR) Issuance of Debt: ₹16.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAKAAR Aakaar Medical Technologies Ltd NSE:AAKAAR
23 GF Score
Price ₹63.00
! 3 Warning Signs
View Full Analysis

What is Aakaar Medical Technologies Issuance of Debt?

Aakaar Medical Technologies NSE:AAKAAR 23 Issuance of Debt is ₹16.5 Mil as of Mar. 2026. GuruFocus rates NSE:AAKAAR with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Aakaar Medical Technologies's Issuance of Debt for the six months ended in Mar. 2026 was ₹14.2 Mil.

Aakaar Medical Technologies's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was ₹16.5 Mil.

Aakaar Medical Technologies Issuance of Debt Related Terms

Aakaar Medical Technologies Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Aakaar Medical Technologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aakaar Medical Technologies Issuance of Debt Chart

Aakaar Medical Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Issuance of Debt
0.00 0.00 91.82 76.82 0.00

Aakaar Medical Technologies Semi-Annual Data
Sep25 Mar26
Issuance of Debt 0.00 14.19
NSE:AAKAAR
23GF Score
Aakaar Medical Technologies Ltd NSE:AAKAAR
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aakaar Medical Technologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹16.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of ₹16.5 Mil mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Issuance of Debt of ₹16.5 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Aakaar Medical Technologies and its competitors.
Is Aakaar Medical Technologies' Issuance of Debt too high?
Aakaar Medical Technologies' current Issuance of Debt is ₹16.5 Mil. Overall, Aakaar Medical Technologies has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Issuance of Debt compare to ABT and SYK?
Aakaar Medical Technologies' Issuance of Debt of ₹16.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Aakaar Medical Technologies and its competitors. Aakaar Medical Technologies's current Issuance of Debt is ₹16.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Issuance of Debt of ₹16.5 Mil. The current Issuance of Debt is ₹16.5 Mil. Aakaar Medical Technologies' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Issuance of Debt is ₹16.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aakaar Medical Technologies Business Description

Address Telli Galli Cross Road, A - 801, Heritage Plaza, Andheri East, Mumbai, MH, IND, 400 069
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
23GF Score

Get the complete analysis for NSE:AAKAAR

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹63.00
Price